Year | Location | Facility | Population | Sample size | Study design | Specimen type | S. aureus detection | MRSA detection | Reference |
1996-01 | Kilifi | Public | Children | 2100 | Retrospective | Blood | 5% (106/2100) | 1% (1/106) | [12] |
2003-08 | Nairobi | Private | All age | 18750 | Retrospective | Blood | 2% (368/18750) | 21% (76/364) | [13] |
2005-07 | Nairobi | Public & private | All age | 179 | Prospective, multicenter | SSTIs | 45.8% (82/179) | 84.1% (69/82) | [14] |
2010 | Nairobi | Private | HCWs | 246 | Prospective | Nasal swabs | 18.3% (45/246) | 0 | [20] |
2011 | Thika | Public | All age | 733 | Prospective cross-sectional | Carriage swabs | 10% (74/733) | 7% (6/86) | [19] |
2012 | Nairobi | Public | Pediatric ICU | 218 | Prospective | Swabs & tracheal aspirates | 32.6% (71/218) | 46.5% (33/71) | [16] |
2011-13 | Nairobi | Private | All age | NR | Retrospective | Heterogeneous | NR (n = 731) | 3.7% (27/731) | [22] |
2014 | Nairobi | Public | Pediatric/ Surgical | 150 | Prospective | Wounds | 52.6% (79/150) | 50.6% (40/79) | [17] |
2014-16 | Nairobi | Public | All age | NR | Retrospective | Heterogeneous | NR (n = 944) | 27.8% (232/831) | [23] |
2014-16 | Nairobi | Public | Adults | 187 | Hybrid | Heterogeneous | NR | 53.4% (100/187) | [24] |
2010-11 | Rift valley | Public | All age | NR | Retrospective | Heterogeneous | NR (n = 107) | 36.5% (39/107) | [15] |
2015 | Nairobi | Public | HCWs | 180 | Prospective | Nasal & hands swabs | 34.4% (62/180) | 59.7% 37/62 | [21] |
2015-16 | Nairobi, Kisumu & Kericho | Public | All age | 221 | Prospective | Heterogeneous | 24.4% (54/221) | 11% (6/54) | [9] |